CIDRAP newsletters options
Health officials in Washington state recently announced an investigation into a similar local case in the Tacoma area.
Approval of an injectable monoclonal antibody offers an easier delivery option and could broaden use of the COVID preventive.
NYC has now reported 4 deaths among 101 Legionnaire's cases, and 15 people are currently hospitalized.
The move is the latest by HHS Secretary Kennedy to put the vaccines recommended for US children under new scrutiny.
One of two circulating genotypes has been identified in Mennonite groups in eight countries, including the US, Canada, and Mexico.
More than a third of US adults are unfamiliar with HPV, and more than 70% are unaware it causes oral cancers.
Uptake of the Tdap and MenACWY vaccines increased among 13- to 17-year-olds in 2024, while HPV vaccine coverage remained unchanged for the third straight year.
The at-home FluMist option, the first of its kind, is available in 34 states for the upcoming flu season.
Officials have confirmed five Oropouche virus-related deaths this year, all in Brazil.
Low flu vaccination rates among adults and children are prompting innovation in reaching patients.
A new infection in an unvaccinated child raises Colorado's 2025 total to 17.
A genomic study of malaria samples from Tanzania and Zanzibar found mutations connected to artemisinin partial resistance, which can lead to poor treatment outcomes.
The vaccines are less likely to be tied to vaccine-associated paralytic polio and seeding of new circulating vaccine-derived polioviruses.
Missouri health officials have announced a lab-confirmed a case of Naegleria fowleri infection, which can destroy brain tissue.
The authors say that, absent a standard definition, the condition will continue to be both under- and over-recognized.
Children continue to be affected by COVID, and, during last winter's rise in cases, emergency department visits were elevated for young children.
When symptoms were described as lasting 2 days, only 31% of clinicians recommended treatment.
Only 37% and 22% reported receipt of flu and COVID vaccines, respectively.
Although dalbavancin was not found to be superior to standard therapy, investigators say the clinical efficacy results indicate it's a viable option.
Data from 412 US hospitals from 2018 through 2023 show 4.5% of patients received an antifungal, a finding researchers say warrants a specific focus on antifungal stewardship.
